BIOMAT Database Logo BIOMAT Database Logo

Transcription factors are potential therapeutic targets in epilepsy. 2022

Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.

Academics generally believe that imbalance between excitation and inhibition of the nervous system is the root cause of epilepsy. However, the aetiology of epilepsy is complex, and its pathogenesis remains unclear. Many studies have shown that epilepsy is closely related to genetic factors. Additionally, the involvement of a variety of tumour-related transcription factors in the pathogenesis of epilepsy has been confirmed, which also confirms the heredity of epilepsy. In this review, we summarize the existing research on a variety of transcription factors and epilepsy and present relevant evidence related to transcription factors that may be targets in epilepsy. This information is of great significance for revealing the in-depth molecular and cellular mechanisms of epilepsy.

UI MeSH Term Description Entries
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Transcription factors as potential targets for therapeutic drugs.
July 2000, Current pharmaceutical biotechnology,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Transcription factors and potential therapeutic targets for pulmonary hypertension.
January 2023, Frontiers in cell and developmental biology,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
December 2018, Veterinary and comparative oncology,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
B cell transcription factors: Potential new therapeutic targets for SLE.
January 2014, Clinical immunology (Orlando, Fla.),
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
HOX transcription factors are potential targets and markers in malignant mesothelioma.
February 2016, BMC cancer,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Astrocyte mitochondria: Potential therapeutic targets for epilepsy.
May 2024, Heliyon,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
February 2009, British journal of cancer,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Transcription factors as therapeutic targets for diabetes.
November 2008, Expert opinion on therapeutic targets,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Transcription factors as therapeutic targets in CNS disorders.
November 2009, Recent patents on CNS drug discovery,
Qihan Sun, and Wenbo Xu, and Jingjing Piao, and Jingyun Su, and Tongtong Ge, and Ranji Cui, and Wei Yang, and Bingjin Li
Transcription factors as therapeutic targets in lymphoid malignancies.
January 2007, International reviews of immunology,
Copied contents to your clipboard!